The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals' single-pill antiretroviral for HIV-1 patients, BI said Tuesday.
A former MedFusionRx VP has joined BioPlus as its new chief strategic officer.
A drug used to treat pain in cancer patients now is available in the United States.
Specialty pharmacy group Assured Pharmacy said that same-store sales for January totaled $1.42 million, a 28.5% increase over the year-ago period.
Usually, when the Food and Drug Administration approves a commercial version of a drug, it prohibits compounding pharmacies from producing it, but it’s making an exception in the case of a drug used to prevent premature births.
A specialty infusion pharmacy has joined the social media realm.
BioPlus Specialty Pharmacy has promoted its supervisor of Rx coordinators.
Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.
For many patients, the inability to pay for drugs is enough of a problem, but what if the drugs they need aren’t available at all?
A group representing specialty pharmacies is calling on the Department of Defense to not use exclusive networks in the Tricare pharmacy program.